What's new in regenerative medicine: Split up of the mesenchymal stem cell family promises new hope for cardiovascular repair

Journal of Cardiovascular Translational Research

Volumn 5, Issue 5, 2012, Pages 689-699

  Vono, Rosa ^a   Spinetti, Gaia ^a   Gubernator, Miriam ^b   Madeddu, Paolo ^b  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Coronary artery disease; Mesenchymal stem cells; Pericytes; Regenerative medicine

Indexed keywords

ANGIOPOIETIN; MICRORNA 132; VASCULOTROPIN A; BIOLOGICAL MARKER;

ANGIOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIAC STEM CELL; CARDIOVASCULAR CELL THERAPY; CARDIOVASCULAR PROCEDURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL TYPE; CORONARY ARTERY DISEASE; DRUG MECHANISM; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DEVELOPMENT; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SAPHENOUS VEIN; STEM CELL; STEM CELL EXPANSION; TISSUE REPAIR; ANIMAL; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REGENERATION; REVIEW; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; PERICYTES; PHENOTYPE; REGENERATION; REGENERATIVE MEDICINE; TREATMENT OUTCOME;

EID: 84874181981     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9395-2     Document Type: Article

References (65)

1. Strauer, B. E.; et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913-8.
2. Ieda, M.; and Fukuda, K. (2012). Cardiomyocyte generation using stem cells and directly reprogrammed cells. Front Biosci (Schol Ed), 4, p. 1413-23.
3. Assmus, B.; et al. (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation, 106(24), 3009-17.
4. Psaltis, P. J.; et al. (2008). Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells, 26(9), 2201-10.
5. Martin-Rendon, E.; et al. (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. European Heart Journal, 29(15), 1807-18.
6. Jujo, K.; Ii, M.; Losordo, D. W. (2008). Endothelial progenitor cells in neovascularization of infarcted myocardium. Journal of Molecular and Cellular Cardiology, 45(4), 530-44.
7. Oikawa, A.; et al. (2010). Diabetes mellitus induces bone marrow microangiopathy. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(3), 498-508.
8. Salem, H. K.; Thiemermann, C. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 28(3), 585-96.
9. Gnecchi, M.; Danieli, P.; Cervio E. (2012). Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol, 57(1), 48-55.
10. Dupont, S.; et al. (2011). Role of YAP/TAZ in mechanotransduction. Nature, 474(7350), 179-83.
11. Shi, Y.; et al. (2012). How mesenchymal stem cells interact with tissue immune responses. Trends in Immunology, 33(3), 136-43.
12. Bartunek, J.; et al. (2008). Mesenchymal stem cells and cardiac repair: principles and practice. Journal of Cardiovascular Translational Research, 1(2), 115-9.
13. Mansilla, E.; et al. (2006). Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplantation Proceedings, 38(3), 967-9.
14. Uccelli, A.; Moretta, L.; Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726-36.
15. Ceradini, D. J.; et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858-64.
16. Wynn, R. F.; et al. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 104(9), 2643-5.
17. Sarkar, D.; et al. (2008). Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjugate Chemistry, 19(11), 2105-9.
18. Sarkar, D.; et al. (2010). Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials, 31(19), 5266-74.
19. Toma, C.; et al. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93-8.
20. Huang, X. P.; et al. (2010). Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation, 122(23), 2419-29.
21. Quevedo, H. C.; et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 14022-7.
22. He, Z.; et al. (2011). Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes. Stem Cells and Development, 20(10), 1771-8.
23. Armiñán, A.; et al. (2009). Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells and Development, 18(6), 907-18.
24. Durocher, D.; et al. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO Journal, 16(18), 5687-96.
25. Chang, S. A.; et al. (2008). Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells, 26(7), 1901-12.
26. Pittenger, M. F.; Martin, B. J. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research, 95(1), 9-20.
27. Jeong, J. O.; et al. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circulation Research, 108(11), 1340-7.
28. Rose, R. A.; Keating, A.; Backx, P. H. (2008). Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes? Circulation Research, 103(9), e120.
29. Siegel, G.; et al. (2012). Bone Marrow-Derived Human Mesenchymal Stem Cells Express Cardiomyogenic Proteins But Do Not Exhibit Functional Cardiomyogenic Differentiation Potential. Stem Cells Dev. doi: 10.1089/scd.2011.0626.
30. Lai, R. C.; et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4(3), 214-22.
31. Nakanishi, C.; et al. (2008). Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochemical and Biophysical Research Communications, 374(1), 11-6.
32. Dellavalle, A.; et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology, 9(3), 255-67.
33. Morosetti, R.; et al. (2011). Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration. Acta Myol, 30(1), 24-8.
34. Bosch, J.; et al. (2012). Distinct Differentiation Potential of "MSC" Derived from Cord Blood and Umbilical Cord: Are Cord-Derived Cells True Mesenchymal Stromal Cells? Stem Cells Dev, 21(11), 1977-88.
35. Invernici, G.; et al. (2008). Human fetal aorta-derived vascular progenitor cells: identification and potential application in ischemic diseases. Cytotechnology, 58(1), 43-7.
36. Corselli, M.; et al. (2012). The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells and Development, 21(8), 1299-308.
37. Crisan, M.; et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 3(3), 301-13.
38. Ergün, S.; Tilki, D.; Klein, D. (2011). Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxidants & Redox Signaling, 15(4), 981-95.
39. Klein, D.; et al. (2011). Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS One, 6(5), e20540.
40. Campagnolo, P.; et al. (2010). Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation, 121(15), 1735-45.
41. Dellavalle, A.; et al. (2011). Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nature Communications, 2, 499.
42. Galvez, B. G.; et al. (2008). Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death and Differentiation, 15(9), 1417-28.
43. Pasquinelli, G.; et al. (2007). Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells, 25(7), 1627-34.
44. Zimmerlin, L.; et al. (2011). Stromal vascular progenitors in adult human adipose tissue. Cytometry. Part A, 77(1), 22-30.
45. Cai, X.; et al. (2009). Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Reviews, 5(4), 437-45.
46. Hirschi, K. K.; D'Amore, P. A. (1996). Pericytes in the microvasculature. Cardiovascular Research, 32(4), 687-98.
47. Stewart, K. S.; et al. (2011). Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation. Blood, 117(2), 719-26.
48. Al Haj Zen, A.; et al. (2010). Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circulation Research, 107(2), 283-93.
49. Brighton, C. T.; et al. (1992). The pericyte as a possible osteoblast progenitor cell. Clinical Orthopaedics and Related Research, 275, 287-99.
50. Diaz-Flores, L.; et al. (1992). Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clinical Orthopaedics and Related Research, 275, 280-6.
51. Richardson, R. L.; Hausman, G. J.; Campion, D. R. (1982). Response of pericytes to thermal lesion in the inguinal fat pad of 10-day-old rats. Acta Anat (Basel), 114(1), 41-57.
52. Barcelos, L. S.; et al. (2009). Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circulation Research, 104(9), 1095-102.
53. Invernici, G.; et al. (2007). Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. American Journal of Pathology, 170(6), 1879-92.
54. Katare, R.; et al. (2011). Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circulation Research, 109(8), 894-906.
55. Fossett, E.; et al. (2012). Effect of age and gender on cell proliferation and cell surface characterization of synovial fat pad derived mesenchymal stem cells. Journal of Orthopaedic Research, 30(7), 1013-8.
56. Stolzing, A.; et al. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mechanisms of Ageing and Development, 129(3), 163-73.
57. Muschler, G. F.; et al. (2001). Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. Journal of Orthopaedic Research, 19(1), 117-25.
58. Ray, R.; et al. (2008). Sex steroids and stem cell function. Molecular Medicine, 14(7-8), 493-501.
59. Barile, L.; et al. (2007). Endogenous cardiac stem cells. Progress in Cardiovascular Diseases, 50(1), 31-48.
60. Anversa, P.; Kajstura, J. (1998). Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circulation Research, 83(1), 1-14.
61. Urbanek, K.; et al. (2006). Stem cell niches in the adult mouse heart. Proceedings of the National Academy of Sciences of the United States of America, 103(24), 9226-31.
62. Linke, A.; et al. (2005). Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proceedings of the National Academy of Sciences of the United States of America, 102(25), 8966-71.
63. Urbanek, K.; et al. (2005). Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proceedings of the National Academy of Sciences of the United States of America, 102(24), 8692-7.
64. Makkar, R. R.; et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet, 379(9819), 895-904.
65. Lahteenvuo, J. E.; et al. (2009). Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation, 119(6), 845-56.